𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ cooperative group

✍ Scribed by M. González-Barón, J. Feliu, E. Espinosa…

Book ID
120776390
Publisher
Springer
Year
1995
Tongue
English
Weight
446 KB
Volume
36
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with advanced gast
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group
✍ J. Feliu; M. González Barón; C. García-Girón; E. Espinosa; P. García-Alfonso; J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

## Background: Both the biochemical modulation and the continuous administration of 5-fluorouracil (5-fu) have achieved promising results in patients with gastric carcinoma. conversely, several studies on gastric carcinoma have demonstrated that the combination of etoposide (vp-16), leucovorin (lv)

A phase ii study of the combination of e
A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer
✍ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc

Phase II study of a modified combination
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer
✍ Içli, Fikri; Karaoguz, Handan; Akbulut, Hakan; Dinçol, Dilek; Demirkazik, Ahmet; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Background: Based on the promising results of eap (etoposide, doxorubicin, and cisplatin) combination, a phase ii study of modified eap combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival. ## Method: Fifty-two consecutive patients